Welcoming two new members to our Strategic Innovation Advisory Board
Graciela Mabel Woloj Rothstein and Mikkel Z. Oestergaard, PhD join the board this March
CancerWorld Special Issue
We’re excited to announce our collaboration with CancerWorld magazine! This special issue is about the 25th anniversary of an oral medication for chronic myeloid leukemia that transformed treatment, diagnostics, access, and patient advocacy.
It features articles from the global community, including clinicians, researchers, patients, and advocates. Learn more about how a woman living with CML started helping others navigate their diagnosis, or the successes and challenges that come with providing treatment in a low-income country. Each voice has something special to share.
The Max Foundation is a leading global health nonprofit organization dedicated to accelerating health equity. For 28 years, Max has pioneered practical, scalable, high-quality solutions to bring life-extending treatments and patient-centered health care to more than 100,000 people living with cancer and critical illness in low- and middle-income countries. Max believes in a world where all people can access high-impact medicines, where geography is not destiny, and where everyone can strive for health with dignity and with hope.
Related Articles
Pat Garcia-Gonzalez joins shortlist of nominees for UICC’s Outstanding Contribution to Cancer Control Award
Pat joins Paul Farmer, President Joe Biden, and other world leaders in “Driving innovation to advance cancer control equitably”
The Max Foundation Announces CancerPath to Care to Treat Up to 36,000 People Living with Leukemia, Breast and Certain Rare Cancers in Over 70 Low- and Middle-income Countries by 2025
New initiative expands existing collaboration with Novartis focused on chronic myeloid leukemia and other rare cancers, to support patient access to care for breast cancer, the leading cause of death in women globally